摘要
人巨细胞病毒（HCMV）感染是实体器官移植后最常见的并发症之一，是导致移植物失功和移植受者发病甚至死亡的主要原因。为此，对移植受者进行必要的预防性抗病毒治疗是降低移植失败和提高移植受者生存率的关键所在，而普遍预防和抢先治疗是两种常见而有效的预防策略。
Human cytomegalovirus infection is one of the most common complications after organ transplantation, and also is a major cause of graft nonftmction and the leading cause of morbidity and mortality in solid organ transplant recipients. Therefore, the key point of decreasing transplant failure and increasing the survival rate of transplant recipients is the employment of antiviral prophylactic therapy. Two common and potent strategies are universal prophylaxis and pre-emptive therapy.
出处
《国际流行病学传染病学杂志》
CAS
2009年第4期258-261,共4页
International Journal of Epidemiology and Infectious Disease
基金
国家973项目（2007CB513005）
国家自然科学基金（30471631、30872239）
关键词
巨细胞病毒
器官移植
预防
治疗
Cytomegalovirus
Organ trsplantafion
Prophylaxis
Therapy
